Genmab — December 2017
-
right away i want to reserve the right to become pissed again when we go from 2500-2031
-
Genmab Looks Attractive As Company Raises Its Full-Year Outlook https://seekingalpha.com/article/4133008-genmab-looks-attractive-company-raises-full-year-outlook
-
By How much E.L.?
-
https://www.tlv.se/beslut/beslut-lakemedel/overklagade-beslut/pagaende/Beslut-att-avsla-ansokan-om-subvention-for-Darzalex-har-overklagats/ - Janssen accepterer ikke bare at de nationale myndigheder ikke kan se fordelen ved Darzalex i Sverige - positivt
-
Patent på CD3xCD20 http://www.freshpatents.com/-dt20171214ptan20170355767.php
-
Mornings! Mon ikke der er sendt IND ansøgning på cd3cd20 nu? Har vi i øvrigt fået target på den? Var der ikke tale om noget autoimmunt også?
-
Se under flyvere i linket
-
tweetchat Transcript, on SMM, seems ASCENT trial will start Q1 18 - https://www.symplur.com/healthcare-hashtags/MMSM/transcript/?hashtag=MMSM&fdate=12%2F20%2F2017&shour=13&smin=0&tdate=12%2F20%2F2017&thour=14&tmin=0
-
Det har været længe undervejs. Været "på trapperne" i 1½ år nu. http://bsri.myeloma.org/ascent-trial/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind